Precision Treatment With Angiotensin Converting Enzyme Inhibitor
NCT05535595
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
77
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
genotyping and selection of renin-angiotensin system blocker
DRUG:
Perindopril
Sponsor
Yonsei University